Truist Financial analyst Asthika Goonewardene reiterated a Buy rating on Exelixis today and set a price target of $51.00. According to TipRanks, Goonewardene is an analyst with an average return of -3 ...
Friday was the deadline for the Metropolitan Police Department (MPD) to respond to a request from councilmembers concerning immigration coordination amid the federal surge and allegations that the ...
Nick Van Exel has played in the NBA, hit big shots on the biggest stage and carved out a long pro career. But when he talks about pure basketball joy, his mind always goes back to one place, back to ...
– STELLAR-316 will use Natera’s Signatera™ assay to identify MRD-positive patients for trial enrollment and to monitor response to therapy – Exelixis, Inc. (Nasdaq: EXEL) and Natera (Nasdaq: NTRA), a ...
Exelixis, Inc. (Nasdaq: EXEL) and Natera (Nasdaq: NTRA), a global leader in cell-free DNA and precision medicine, today announced their collaboration on the planned Exelixis-sponsored STELLAR-316 ...
WASHINGTON (AP) — President Donald Trump's withdrawal from the entire United Nations climate-fighting apparatus takes America's environmental isolation to another level and is likely to damage both ...
WASHINGTON (AP) — When President Donald Trump announced the audacious capture of Nicolás Maduro to face drug trafficking charges in the U.S., he portrayed the strongman’s vice president and longtime ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results